| CARIPRAZINE |
Reagila® |
Seqirus (Australia) Pty Ltd |
Schizophrenia |
Nov 2020 |
Recommended |
| DAPAGLIFLOZIN |
Forxiga® |
AstraZeneca Pty Ltd |
Heart failure |
Nov 2020 |
Not Recommended |
| DURVALUMAB |
Imfinzi® |
AstraZeneca Pty Ltd |
Small cell lung cancer (SCLC) |
Nov 2020 |
Recommended |
| EVOLOCUMAB |
Repatha® |
Amgen Australia Pty Limited |
Familial heterozygous hypercholesterolaemia, Non-familial hypercholesterolaemia |
Nov 2020 |
Not Recommended |
| GALCANEZUMAB |
Emgality® |
Eli Lilly Australia Pty Ltd |
Episodic migraine |
Nov 2020 |
Not Recommended |
| VEDOLIZUMAB |
Entyvio® |
Takeda Pharmaceuticals Australia Pty Ltd |
Ulcerative colitis Crohn's disease |
Nov 2020 |
Recommended |
| RIBOCICLIB |
Kisqali® |
Novartis Pharmaceuticals Australia Pty Ltd |
Locally advanced or metastatic breast cancer |
Nov 2020 |
Recommended |
| SECUKINUMAB |
Cosentyx® |
Novartis Pharmaceuticals Australia Pty Limited |
Non-radiographic axial spondyloarthritis |
Nov 2020 |
Recommended |
| ONASEMNOGENE ABEPARVOVEC |
Zolgensma® |
Novartis Pharmaceuticals Australia Pty Limited |
Spinal muscular atrophy (SMA) |
Nov 2020 |
Deferred |
| NIVOLUMAB AND IPILIMUMAB |
Opdivo® Yervoy® |
Bristol-Myers Squibb Australia Pty Ltd |
Non-small cell lung cancer (NSCLC) |
Nov 2020 |
Recommended |
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dome (Australia) Pty Ltd |
Squamous cell carcinoma of the head and neck (SCCHN) |
Nov 2020 |
Not Recommended |
| INFLIXIMAB |
Remsima® SC |
Celltrion Healthcare Australia Pty Ltd |
Rheumatoid arthritis Ankylosing spondylitis Psoriatic arthritis Chronic plaque psoriasis
Crohn’s disease Complex refractory fistulising Crohn’s disease Ulcerative colitis |
Nov 2020 |
Recommended |
| GUSELKUMAB |
Tremfya® |
Janssen-Cilag Pty Ltd |
Psoriatic arthritis |
Nov 2020 |
Recommended |
| ADALIMUMAB |
Hadlima® |
Merck Sharp & Dome (Australia) Pty Ltd |
Severe Crohn disease; complex refractory fistulising Crohn disease; moderate to severe
ulcerative colitis; severe active juvenile idiopathic arthritis; adult patients with
a history of jovenile idiopathic arthritis; severe psoriatic arthritis; ankylosing
spondylitis; severe chronic plaque psoriasis; severe active rheumatoid arthritis |
Nov 2020 |
Deferred |
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN |
Ga Gel® Ga Express 15® |
Vitaflo Australia Pty Limited |
Pyridoxine Dependent Epilepsy |
Nov 2020 |
Recommended |
| BECLOMETASONE WITH FORMOTEROL AND GLYCOPYRRONIUM |
Trimbow® |
Chiesi Australia Pty Ltd |
Chronic obstructive pulmonary disease (COPD) |
Nov 2020 |
Recommended |
| SACUBITRIL WITH VALSARTAN |
Entresto® |
Novartis Pharmaceuticals Australia Pty Limited |
Heart failure |
Nov 2020 |
Not Recommended |
| TOFACITINIB |
Xeljanz® |
Pfizer Australia Pty Ltd |
Ulcerative colitis and other listed indications |
Nov 2020 |
Recommended |
| PROGESTERONE |
Oripro® |
Orion Laboratories Pty. Ltd. |
Prevention of preterm birth |
Nov 2020 |
Recommended |
| ADRENALINE |
Anapen® |
Allergy Concepts Pty Ltd |
Acute allergic reaction with anaphylaxis |
Nov 2020 |
Recommended |
| APOMORPHINE |
Movapo PFS® |
Stada Pharmaceuticals Australia Pty Ltd |
Parkinson's disease |
Nov 2020 |
Recommended |
| GALCANEZUMAB |
Emgality® |
Eli Lilly Australia Pty Ltd |
Treatment-resistant chronic migraine |
Nov 2020 |
Recommended |
| FILGOTINIB |
Jyseleca® |
Gilead Sciences Pty Ltd |
Rheumatoid arthritis |
Nov 2020 |
Not Applicable |
| HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND
CARBOHYDRATE |
Ketovie® |
Cortex Health Pty Ltd |
Ketogenic diet |
Nov 2020 |
Recommended |
| PANCREATIC EXTRACT |
Creon® |
Mylan Health Pty Ltd |
Pancreatic exocrine insufficiency |
Nov 2020 |
Recommended |
| CEMIPLIMAB |
Libtayo® |
Sanofi-Aventis Australia Pty Ltd |
Squamous cell carcinoma (SCC) |
Nov 2020 |
Not Recommended |
| DEFERASIROX |
Deferasirox Juno® |
Juno Pharmaceuticals Pty Ltd |
Chronic iron overload |
Nov 2020 |
Recommended |
| ECULIZUMAB |
Soliris® |
Alexion Pharmaceuticals Australasia Pty Ltd |
Neuromyelitis optica spectrum disorder (NMOSD) |
Nov 2020 |
Not Recommended |
| IXAZOMIB |
Ninlaro® |
Takeda Pharmaceuticals Australia Pty Ltd |
Multiple myeloma |
Nov 2020 |
Not Recommended |
| MESALAZINE |
Asacol® |
Chiesi Australia Pty Ltd |
Ulcerative colitis |
Nov 2020 |
Recommended |
| NUSINERSEN |
Spinraza® |
Biogen Australia Pty Ltd |
Spinal muscular atrophy (SMA) |
Nov 2020 |
Not Recommended |
| BEVACIZUMAB |
Mvasi® |
Amgen Australia Pty Limited |
Metastatic colorectal cancer Epithelial ovarian, fallopian tube, or primary peritoneal
cancer, cervical cancer, Stage IV glioma, non-small cell lung cancer (NSCLC) |
Nov 2020 |
Recommended |
| ADALIMUMAB |
Idacio® |
Fresenius Kabi Australia Pty Limited |
Severe Crohn disease; Moderate to severe ulcerative colitis; Severe active juvenile
idiopathic arthritis; Complex refractory Fistulising Crohn disease; Severe active
rheumatoid arthritis; Severe psoriatic arthritis; Ankylosing spondylitis; Severe chronic
plaque psoriasis; Moderate to severe hidradenitis suppurativa |
Nov 2020 |
Recommended |
| APALUTAMIDE |
Erlyand® |
Janssen-Cilag Pty Ltd |
Prostate cancer |
Nov 2020 |
Not Recommended |
| PATIROMER |
Veltassa® |
Vifor Pharma Pty Limited |
Hyperkalaemia |
Nov 2020 |
Not Recommended |
| SAPROPTERIN |
Kuvan® |
Biomarin Pharmaceutical Australia Pty Ltd |
Maternal phenylketonuria (MPKU) |
Nov 2020 |
Deferred |
| PROGESTERONE |
Utrogestan® |
Besins Healthcare Australia Pty Ltd |
Prevention of preterm birth |
Nov 2020 |
Recommended |
| DUPILUMAB |
Dupixent® |
Sanofi-Aventis Australia Pty Ltd |
Asthma |
Nov 2020 |
Recommended |
| CRISABOROLE |
Staquis® |
Pfizer Australia Pty Ltd |
Atopic dermatitis |
Nov 2020 |
Not Recommended |
| UPADACITINIB |
Rinvoq® |
AbbVie Pty Ltd |
Severe rheumatoid arthritis |
Nov 2020 |
Not Applicable |
| MOGAMULIZUMAB |
Poteligeo® |
Kyowa Kirin Australia Pty Ltd |
Cutaneous T-Cell Lymphoma (CTCL) |
Nov 2020 |
Not Recommended |
| OBETICHOLIC ACID |
Ocaliva® |
Chiesi Australia Pty Ltd |
Primary biliary cholangitis |
Nov 2020 |
Deferred |
| GLECAPREVIR + PIBRENTASVIR |
Maviret® |
AbbVie Pty Ltd |
Chronic Hepatitis C infection |
Nov 2020 |
Deferred |
| CABOZANTINIB |
Cabometyx® |
Ipsen Pty Ltd |
Renal cell carcinoma |
Nov 2020 |
Recommended |
| LAROTRECTINIB |
Vitrakvi® |
Bayer Australia Ltd |
Solid tumours harbouring neurotrophic receptor tyrosine kinase (NTRK) gene fusions |
Nov 2020 |
Deferred |
| ELOTUZUMAB |
Empliciti® |
Bristol-Myers Squibb Australia Pty Ltd |
Multiple myeloma |
Nov 2020 |
Not Recommended |
| IBRUTINIB |
Imbruvica® |
Janssen-Cilag Pty Ltd |
Chronic lymphocytic leukaemia (CLL); small lymphocytic lymphoma (SLL); mantle cell
lymphoma |
Nov 2020 |
Recommended |
| FLUOCINOLONE ACETONIDE |
Iluvien® |
Specialised Therapeutics Alim Pty Ltd |
Diabetic macular oedema |
Nov 2020 |
Not Recommended |
| TOFACITINIB |
Xeljanz® |
Pfizer Australia Pty Ltd |
Chronic plaque psoriasis Psoriatic arthritis Rheumatoid arthritis Ulcerative arthritis |
Nov 2020 |
Not Applicable |
| CANNABIDIOL |
Epidyolex® |
Emerge Health Pty Ltd |
Lennox-Gastaut syndrome Dravet syndrome |
Nov 2020 |
Recommended |
| DUPILUMAB |
Dupixent® |
Sanofi-aventis Australia Pty Ltd |
Atopic dermatitis |
Nov 2020 |
Recommended |
| INDACATEROL WITH GLYCOPYRRONIUM AND MOMETASONE |
Enerzair Breezhaler® |
Novartis Pharmaceuticals Australia Pty Ltd |
Asthma |
Nov 2020 |
Recommended |